We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Drops Stroke Treatment Drug After Clinical Trial Failure
AstraZeneca Drops Stroke Treatment Drug After Clinical Trial Failure
October 27, 2006
AstraZeneca is stopping any further work on an investigative drug for the neurological damage caused by strokes, after it failed to show any effect compared with placebo in a Phase III clinical trial.